The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsMeta-Analysis Published on 2022-10-012023-07-09 Journal: Expert review of anti-infective therapy [Category] COVID19(2023년), [키워드] COVID-19 Intravenous immunoglobulin IVIG Mortality SARS-CoV-2 [DOI] 10.1080/14787210.2022.2098112 [Article Type] Meta-Analysis
Loss of Taste as an Initial Symptom of a “Facial Diplegia and Paresthesia” Variant of Guillain-Barré SyndromeArticle Published on 2022-10-012022-11-15 Journal: Internal medicine (Tokyo, Japan) [Category] 변종, 진단, [키워드] coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 mRNA Vaccination diplegia facial facial diplegia and paresthesia Guillain-barrè syndrome Gustatory Gustatory disorders Intravenous immunoglobulin Loss loss of taste Patient recovered completely Symptom syndrome Taste therapy vaccination variant [DOI] 10.2169/internalmedicine.9781-22 PMC 바로가기
Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasmaArticle Published on 2022-10-012022-11-15 Journal: Immunotherapy [Category] COVID19(2023년), SARS, 진단, [키워드] administration Adults allergenic animal models anti-SARS-CoV-2 clinical trial Concentration convalescent plasma COVID-19 COVID-globulin development developmental Efficacy hamster healthy hyperimmune hyperimmune immunoglobulin IgG Immunoglobulin immunoglobulin against COVID-19 Immunosuppressed inactivation intravenous Intravenous immunoglobulin investigated material Neutralizing plasma preclinical evaluation produced Protective protective efficacy Protein purification Safe Safety SARS-CoV-2 SARS-CoV-2 neutralizing antibody Toxicity virus [DOI] 10.2217/imt-2022-0015 PMC 바로가기
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationArticle Published on 2022-10-012022-11-15 Journal: Annals of neurology [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI 95% confidence interval adenovirus-based adjusted adjusted odds ratio administration adverse effect analyzed ANN Anticoagulant Anticoagulants association autoimmune pathogenesis avoidance caused cerebral country COVID-19 diagnosed evaluate had no heparin hospital immune immunomodulation International Intravenous immunoglobulin lower mortality Mortality Patient Platelet recommendation reducing mortality SARS-CoV-2 SARS-CoV-2 vaccination significantly statistically significant the patient thrombotic treated Treatment used data Vaccines Venous thrombosis [DOI] 10.1002/ana.26431 PMC 바로가기
Trends in Treatments for Multisystem Inflammatory Syndrome in Children (MIS-C), United States, February 2020 – July 2021Article Published on 2022-09-302022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] acute respiratory syndrome administration Admission Analysis analyzed anticoagulation antiplatelet Black patient Case report CDC center children Clinical findings Clinical management Combination Control coronavirus declined Frequency ICU increasingly Inflammatory intensive care Intravenous immunoglobulin Local medication MIS-C multisystem inflammatory syndrome in children National noninvasive respiratory other treatment Patient patients Postinfectious Prevalence prevention proportion receive reported SARS-CoV-2 severity standard treatment steroid Steroids Support Surveillance syndrome therapy Treatment trend United States Vasoactive Ventilation [DOI] 10.1093/cid/ciac072 PMC 바로가기
A tendency to worse course of multisystem inflammatory syndrome in children with obesity: MultiOrgan Inflammatory Syndromes COVID-19 related studyArticle Published on 2022-09-262022-11-15 Journal: Frontiers in Endocrinology [Category] 진단, [키워드] Abnormalities Analysis available data BMI body mass index childhood Childhood obesity children collected Comorbidity Course COVID-19 COVID-19 infection COVID-19 severity criteria discharge disease entity duration of symptom form Frequency higher risk Hospitalization Inflammatory intensive care Intravenous immunoglobulin MIS-C National no difference obese obesity Odds ratio Oxygen therapy participant pathophysiology Patient patients patients with obesity PIMS Poland populations pro-inflammatory recruited risk factor syndrome Treatment worsening [DOI] 10.3389/fendo.2022.934373 PMC 바로가기
Encephalomyelitis associated with coronavirus disease 2019: a case report코로나바이러스 질병 2019와 관련된 뇌척수염: 사례 보고Case Reports Published on 2022-08-232022-09-12 Journal: Journal of Medical Case Reports [Category] 진단, [키워드] acute respiratory syndrome administration antibody article Asian Case report cerebrospinal fluid clinical Clinical improvement coronavirus coronavirus disease COVID-19 Deterioration diagnosed discharge DNA effective Encephalitis Encephalomyelitis female Fever high-dose methylprednisolone immunomodulator Infection Intravenous immunoglobulin Longitudinally extensive transverse myelitis. Loss of consciousness Manifestations Mild neurological neurological manifestation presenting steroid Symptoms the patient Treatment [DOI] 10.1186/s13256-022-03539-9 PMC 바로가기 [Article Type] Case Reports
Post-COVID-19 Guillain-Barré Syndrome: A case report from OmanArticle Published on 2022-08-012022-11-15 Journal: Sultan Qaboos University medical journal [Category] 진단, [키워드] acute respiratory syndrome Care Case report caused causes Characteristics complication of COVID-19 coronavirus Course COVID-19 COVID-19 infection Diagnosis disorder exclusion FIVE Guillain-barrè syndrome highlight hospital Intravenous immunoglobulin IVIG limb male manifestation Muscat neurological manifestation Oman Patient per day reported syndrome weakness [DOI] 10.18295/squmj.6.2021.090 PMC 바로가기
Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia백신 유도성 혈전성 혈소판 감소증 후 장기 결과Article Published on 2022-08-012022-09-11 Journal: Viruses [Category] SARS, 진단, 치료기술, [키워드] acute phase Adenovirus adenovirus-based affected antibody Anticoagulants anticoagulation appear Arterial thrombosis AZD1222 bleeding cerebral venous sinus thrombosis ChAdOx1 ChAdOx1 nCoV-19 Cohort Cohort studies cohort study Complication coronavirus Corticosteroids COVID-19 D-dimer detectable diagnosed Diagnosis died dimer Direct discharge discharged eculizumab effective elevated enrolled Follow-up hospital hospital discharge Immunoglobulin in some Intravenous immunoglobulin IVIG limit management nCoV neurological nine observation occurred one patient oral anticoagulant outcome Patient patients PF4 Platelet platelet activation positive prothrombotic condition remained respiratory respiratory syndrome coronavirus respiratory syndrome coronavirus 2 Safe SARS-CoV-2 serious complication Seven severe respiratory syndrome single-center Sinus thrombosis survived Symptom symptom onset syndrome the disease thrombocytopenia thromboembolic Thromboembolic event Thromboembolic events thrombosis thrombotic Thrombotic thrombocytopenia Treatment two patients vaccination Vaccine venous venous sinus were given [DOI] 10.3390/v14081702 PMC 바로가기 [Article Type] Article
Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection급성 COVID-19 감염의 주요 증상인 자발적 헤파린 유발 혈소판 감소증으로 인한 사지 허혈Case Reports Published on 2022-08-012022-09-12 Journal: Journal of Thrombosis and Thrombolysis [Category] MERS, 진단, [키워드] 2019 coronavirus disease absence activate acute COVID-19 addition administration antibodies characterized complexes COVID-19 develop enzyme-linked immunosorbent had no heparin Hospitalization IgG antibody immunoglobulins, intravenous Infection instances Intravenous immunoglobulin Ischemia less male occur Pain Patient PF4 Platelet platelet activation positive presenting prothrombotic condition reported Serotonin Spontaneous spontaneous heparin-induced thrombocytopenia SRA syndrome thrombocytopenia thrombosis treated Vaccinations [DOI] 10.1007/s11239-022-02676-8 PMC 바로가기 [Article Type] Case Reports